• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰老表型能否打破平衡促进肿瘤休眠?

Could senescence phenotypes strike the balance to promote tumor dormancy?

机构信息

Department of Biochemistry and Molecular Biology, Tulane School of Medicine, 1430 Tulane Avenue, New Orleans, LA, 70112, USA.

出版信息

Cancer Metastasis Rev. 2023 Mar;42(1):143-160. doi: 10.1007/s10555-023-10089-z. Epub 2023 Feb 3.

DOI:10.1007/s10555-023-10089-z
PMID:36735097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10710690/
Abstract

After treatment and surgery, patient tumors can initially respond followed by a rapid relapse, or respond well and seemingly be cured, but then recur years or decades later. The state of surviving cancer cells during the long, undetected period is termed dormancy. By definition, the dormant tumor cells do not proliferate to create a mass that is detectable or symptomatic, but also never die. An intrinsic state and microenvironment that are inhospitable to the tumor would bias toward cell death and complete eradication, while conditions that favor the tumor would enable growth and relapse. In neither case would clinical dormancy be observed. Normal cells and tumor cells can enter a state of cellular senescence after stress such as that caused by cancer therapy. Senescence is characterized by a stable cell cycle arrest mediated by chromatin modifications that cause gene expression changes and a secretory phenotype involving many cytokines and chemokines. Senescent cell phenotypes have been shown to be both tumor promoting and tumor suppressive. The balance of these opposing forces presents an attractive model to explain tumor dormancy: phenotypes of stable arrest and immune suppression could promote survival, while reversible epigenetic programs combined with cytokines and growth factors that promote angiogenesis, survival, and proliferation could initiate the emergence from dormancy. In this review, we examine the phenotypes that have been characterized in different normal and cancer cells made senescent by various stresses and how these might explain the characteristics of tumor dormancy.

摘要

经过治疗和手术,患者的肿瘤最初可能会有反应,随后迅速复发,或者反应良好,看似治愈,但几年或几十年后又复发。在长时间未被发现的情况下,存活癌细胞的状态被称为休眠。根据定义,休眠的肿瘤细胞不会增殖形成可检测或有症状的肿块,但也不会死亡。不利于肿瘤的内在状态和微环境会偏向于细胞死亡和完全清除,而有利于肿瘤的条件则会使肿瘤生长和复发。在这两种情况下都不会观察到临床休眠。正常细胞和肿瘤细胞在受到癌症治疗等压力后,可以进入细胞衰老状态。衰老的特征是由染色质修饰介导的稳定细胞周期停滞,导致基因表达变化和涉及许多细胞因子和趋化因子的分泌表型。已经表明衰老细胞表型具有促进肿瘤和抑制肿瘤的双重作用。这些相反力量的平衡提供了一个有吸引力的模型来解释肿瘤休眠:稳定的阻滞和免疫抑制表型可以促进存活,而可逆的表观遗传程序与促进血管生成、存活和增殖的细胞因子和生长因子结合,可以引发休眠的出现。在这篇综述中,我们研究了不同的正常细胞和癌细胞在受到各种压力后表现出的衰老特征,以及这些特征如何解释肿瘤休眠的特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6580/10710690/38c23ec5d2f9/nihms-1949376-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6580/10710690/38c23ec5d2f9/nihms-1949376-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6580/10710690/38c23ec5d2f9/nihms-1949376-f0001.jpg

相似文献

1
Could senescence phenotypes strike the balance to promote tumor dormancy?衰老表型能否打破平衡促进肿瘤休眠?
Cancer Metastasis Rev. 2023 Mar;42(1):143-160. doi: 10.1007/s10555-023-10089-z. Epub 2023 Feb 3.
2
Insights into the role of senescence in tumor dormancy: mechanisms and applications.衰老在肿瘤休眠中的作用洞察:机制与应用
Cancer Metastasis Rev. 2023 Mar;42(1):19-35. doi: 10.1007/s10555-023-10082-6. Epub 2023 Jan 21.
3
Can 3D bioprinting solve the mystery of senescence in cancer therapy?3D 生物打印能否解开癌症治疗中衰老的奥秘?
Ageing Res Rev. 2022 Nov;81:101732. doi: 10.1016/j.arr.2022.101732. Epub 2022 Sep 12.
4
Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces.揭开癌症休眠的面纱:内在机制与外在力量。
Cancer Lett. 2024 Jun 1;591:216899. doi: 10.1016/j.canlet.2024.216899. Epub 2024 Apr 21.
5
Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.调控转移性肿瘤休眠及治疗干预新契机
Int J Mol Sci. 2022 Nov 11;23(22):13931. doi: 10.3390/ijms232213931.
6
When dormancy fuels tumour relapse.休眠促进肿瘤复发。
Commun Biol. 2021 Jun 16;4(1):747. doi: 10.1038/s42003-021-02257-0.
7
Dormancy in cancer.癌症休眠。
Cancer Sci. 2019 Feb;110(2):474-480. doi: 10.1111/cas.13917. Epub 2019 Jan 11.
8
Prostate cancer dormancy and recurrence.前列腺癌休眠与复发。
Cancer Lett. 2022 Jan 1;524:103-108. doi: 10.1016/j.canlet.2021.09.037. Epub 2021 Oct 5.
9
Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence.骨髓基质分泌衰老可重新激活休眠的雌激素依赖性人乳腺癌细胞。
Cell Commun Signal. 2018 Aug 17;16(1):48. doi: 10.1186/s12964-018-0259-5.
10
Cellular dormancy in minimal residual disease following targeted therapy.靶向治疗后微小残留病灶中的细胞休眠。
Breast Cancer Res. 2021 Jun 4;23(1):63. doi: 10.1186/s13058-021-01416-9.

引用本文的文献

1
Cellular senescence in colorectal cancer: its occurrence, effect and therapy.结直肠癌中的细胞衰老:其发生、影响及治疗
Front Oncol. 2025 Aug 15;15:1580951. doi: 10.3389/fonc.2025.1580951. eCollection 2025.
2
Cellular Aging and Senescence in Cancer: A Holistic Review of Cellular Fate Determinants.癌症中的细胞衰老与老化:细胞命运决定因素的全面综述
Aging Dis. 2024 May 21;16(3):1483-1512. doi: 10.14336/AD.2024.0421.
3
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research.与 ChatGPT 就衰老和癌症研究中的争议问题进行对话。

本文引用的文献

1
Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80.乳腺癌细胞通过激活靶向免疫调节程序来存活化疗,这些程序的特征是 PD-L1 或 CD80。
Nat Cancer. 2022 Dec;3(12):1513-1533. doi: 10.1038/s43018-022-00466-y. Epub 2022 Dec 8.
2
Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis.将多柔比星的促衰老特性重新用于乳腺癌脑转移的免疫治疗。
Cell Rep Med. 2022 Nov 15;3(11):100821. doi: 10.1016/j.xcrm.2022.100821.
3
Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes.
Mol Pharmacol. 2024 Apr 17;105(5):313-327. doi: 10.1124/molpharm.124.000871.
4
The senescent mesothelial matrix accentuates colonization by ovarian cancer cells.衰老的间皮基质加重了卵巢癌细胞的定植。
Cell Mol Life Sci. 2023 Dec 3;81(1):2. doi: 10.1007/s00018-023-05017-x.
阻断 PD-L1-PD-1 可改善衰老监控和衰老表型。
Nature. 2022 Nov;611(7935):358-364. doi: 10.1038/s41586-022-05388-4. Epub 2022 Nov 2.
4
Senescence Rewires Microenvironment Sensing to Facilitate Antitumor Immunity.衰老重编微环境感应以促进抗肿瘤免疫。
Cancer Discov. 2023 Feb 6;13(2):432-453. doi: 10.1158/2159-8290.CD-22-0528.
5
Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity.细胞衰老具有免疫原性,并能促进抗肿瘤免疫。
Cancer Discov. 2023 Feb 6;13(2):410-431. doi: 10.1158/2159-8290.CD-22-0523.
6
Phosphoinositide species and filamentous actin formation mediate engulfment by senescent tumor cells.磷脂酰肌醇种类和丝状肌动蛋白形成介导衰老肿瘤细胞的吞噬作用。
PLoS Biol. 2022 Oct 24;20(10):e3001858. doi: 10.1371/journal.pbio.3001858. eCollection 2022 Oct.
7
Upregulation of PD-L1 in Senescence and Aging.PD-L1 在衰老和老化中的上调。
Mol Cell Biol. 2022 Oct 20;42(10):e0017122. doi: 10.1128/mcb.00171-22. Epub 2022 Sep 26.
8
Ezh2 Inhibits Replicative Senescence of Atrial Fibroblasts Through Promotion of H3K27me3 in the Promoter Regions of CDKN2a and Timp4 Genes.Ezh2通过促进CDKN2a和Timp4基因启动子区域的H3K27me3来抑制心房成纤维细胞的复制性衰老。
J Inflamm Res. 2022 Aug 16;15:4693-4708. doi: 10.2147/JIR.S374951. eCollection 2022.
9
p53 Activation Paradoxically Causes Liver Cancer.p53 激活悖论性地导致肝癌。
Cancer Res. 2022 Aug 16;82(16):2824-2825. doi: 10.1158/0008-5472.CAN-22-2065.
10
Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes Paradoxically Promotes Non-Cell Autonomous Liver Carcinogenesis.肿瘤抑制因子 p53 在肝细胞中的组成性激活,反而促进了非细胞自主的肝癌发生。
Cancer Res. 2022 Aug 16;82(16):2860-2873. doi: 10.1158/0008-5472.CAN-21-4390.